Stay updated on CA-4948 in CNS Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the CA-4948 in CNS Lymphoma: Clinical Trial page.

Latest updates to the CA-4948 in CNS Lymphoma: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check18 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.3, replacing the previous version v2.16.2. The estimated last update posted has been removed.SummaryDifference0.1%
- Check26 days agoChange DetectedThe page has been updated to reflect a new clinical trial version and the addition of a new physician, Ahmed Hamdy, MD, while removing the previous version's details and the name of Catherine Wang, MD.SummaryDifference1%
- Check33 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check76 days agoChange DetectedThe webpage has been updated to reflect the closure of enrollment for Parts A1 and A2 of the clinical trial evaluating emavusertib, and it now includes detailed descriptions of the trial's structure, including the non-randomized and randomized components of Parts B and C.SummaryDifference31%
Stay in the know with updates to CA-4948 in CNS Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 in CNS Lymphoma: Clinical Trial page.